Lataa...
HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma
PURPOSE: The identification of HER2 overexpression in a subset of gastric adenocarcinoma (GA) patients represents a significant step forward in unveiling the molecular complexity of this disease. The predictive and prognostic value of HER2 amplification in advanced HER2 inhibitor-treated GA patients...
Tallennettuna:
| Julkaisussa: | J Cancer Res Clin Oncol |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Berlin Heidelberg
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8021510/ https://ncbi.nlm.nih.gov/pubmed/33543328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-021-03522-9 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|